首页> 外文期刊>EBioMedicine >Development of a preoperative prediction nomogram for lymph node metastasis in colorectal cancer based on a novel serum miRNA signature and CT scans
【24h】

Development of a preoperative prediction nomogram for lymph node metastasis in colorectal cancer based on a novel serum miRNA signature and CT scans

机译:基于新型血清miRNA签名和CT扫描的结直肠癌淋巴结转移术前术预测诺模图的开发

获取原文
           

摘要

Background Preoperative prediction of lymph node (LN) status is of crucial importance for appropriate treatment planning in patients with colorectal cancer (CRC). In this study, we sought to develop and validate a non-invasive nomogram model to preoperatively predict LN metastasis in CRC. Methods Development of the nomogram entailed three subsequent stages with specific patient sets. In the discovery set ( n ?=?20), LN-status-related miRNAs were screened from high-throughput sequencing data of human CRC serum samples. In the training set ( n ?=?218), a miRNA panel-clinicopathologic nomogram was developed by logistic regression analysis for preoperative prediction of LN metastasis. In the validation set ( n ?=?198), we validated the above nomogram with respect to its discrimination, calibration and clinical application. Findings Four differently expressed miRNAs (miR-122-5p, miR-146b-5p, miR-186-5p and miR-193a-5p) were identified in the serum samples from CRC patients with and without LN metastasis, which also had regulatory effects on CRC cell migration. The combined miRNA panel could provide higher LN prediction capability compared with computed tomography (CT) scans ( P ??.0001 in both the training and validation sets). Furthermore, a nomogram integrating the miRNA-based panel and CT-reported LN status was constructed in the training set, which performed well in both the training and validation sets (AUC: 0.913 and 0.883, respectively). Decision curve analysis demonstrated the clinical usefulness of the nomogram. Interpretation Our nomogram is a reliable prediction model that can be conveniently and efficiently used to improve the accuracy of preoperative prediction of LN metastasis in patients with CRC.
机译:背景术前预测淋巴结(LN)的状态对于结直肠癌(CRC)患者的适当治疗计划至关重要。在这项研究中,我们试图开发和验证一种非侵入性列线图模型,以术前预测CRC中的LN转移。方法诺模图的开发需要三个随后的阶段,分别针对特定的患者。在发现集中(n≥20),从人CRC血清样品的高通量测序数据中筛选LN状态相关的miRNA。在训练组(n = 218)中,通过logistic回归分析开发了miRNA面板临床病理列线图,用于术前预测LN转移。在验证集中(n≥198),我们就鉴别,校准和临床应用对上述列线图进行了验证。结果在患有和不伴有LN转移的CRC患者血清中鉴定出四种不同表达的miRNA(miR-122-5p,miR-146b-5p,miR-186-5p和miR-193a-5p),它们也具有调节作用CRC细胞迁移。与计算机断层扫描(CT)扫描相比,组合的miRNA面板可以提供更高的LN预测能力(训练集和验证集中的P 。0001)。此外,在训练集中构建了综合基于miRNA的面板和CT报告的LN状态的列线图,在训练和验证集中均表现良好(AUC:分别为0.913和0.883)。决策曲线分析证明了列线图的临床实用性。解释我们的列线图是一种可靠的预测模型,可以方便有效地用于提高CRC患者术前LN转移的预测准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号